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BACKGROUND: Worry about recurrence (worry) is a persistent concern of breast cancer survivors. Little is known
about whether race/ethnicity or healthcare experiences are associated with worry. METHODS: Women with nonmeta-
static breast cancer diagnosed from June 2005 to February 2007 and reported to Detroit or Los Angeles Surveil-
lance, Epidemiology, and End Results registries were surveyed (mean 9 months postdiagnosis); 2290 responded
(73%). Latinas and African Americans were oversampled. A worry scale was constructed as the mean score of 3 items
(on 5-point Likert, higher ¼ more worry): worry about cancer returning to the same breast, occurring in the other
breast, or spreading to other parts of the body. Race/ethnicity categories were white, African American, and Latina
(categorized into low vs high acculturation). The worry scale was regressed on sociodemographics, clinical/treat-
ment, and healthcare experience factors (eg, care coordination collapsed into low, medium, high). RESULTS: Low
acculturated Latinas reported more worry and African Americans less worry than whites (P < .001). Other factors in-
dependently associated with more worry were younger age, being employed, more pain and fatigue, and radiation
(Ps < .05). With all factors in the model, less worry was associated (all Ps < .05) with greater ease of understanding
information (2.89, 2.99, 2.81 for low, medium, high), better symptom management (3.19, 2.89, 2.87 for low, medium,
high), and more coordinated care (3.36, 2.94, 2.82 for low, medium, high). Race/ethnicity remained significant con-
trolling for all factors (P < .001). CONCLUSIONS: Less acculturated Latina breast cancer patients are vulnerable to
high levels of worry. Interventions that improve information exchange, symptom management, and coordinating care
hold promise in reducing worry. Cancer 2011;117:1827–36. VC 2011 American Cancer Society.
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Because of advances in early detection and treatment, most women with early stage breast cancer face an optimistic
future. As more women survive breast cancer, interest has increased regarding quality of life (QOL) issues in survivorship.
The transition between active treatment and early survivorship is a vulnerable point in recovery, with the quality of adjust-
ment affecting future well-being of survivors. Survivors consistently rank worry about recurrence (hereafter referred to as
worry) among their most pressing concerns,1-3 and one that persists well into survivorship.2,4-7
Helping survivors understand and manage their worry is a priority identified by the Institute of Medicine (IOM).8
Greater focus on worry is essential given the documented impact worry has on treatment decision making, surveillance
behaviors, and QOL. Women who have more concerns about recurrence are more likely to choose mastectomy9-11 and
get bilateral versus single mastectomy.9 Increased worry can deter women from seeking appropriate follow-up care or may
encourage maladaptive behaviors such as excessive checking.1,12 Several studies have shown that high levels of worry can
lead to depression, anxiety,1,7,13 and decreased QOL.2,7,14-16
DOI: 10.1002/cncr.25740, Received: June 29, 2010; Revised: September 9, 2010; Accepted: September 27, 2010, Published online March 28, 2011 in Wiley
Online Library (wileyonlinelibrary.com)
Corresponding author: Nancy K. Janz, PhD, UM School of Public Health, 1415 Washington Heights, Ann Arbor, MI 48109-2029; Fax: (734) 763-9115;
nkjanz@umich.edu
1Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan; 2Veterans Administration Center for
Practice Management and Outcomes Research, Ann Arbor VA Health Care System, Ann Arbor, Michigan; 3Division of General Medicine, Department of Internal
Medicine, University of Michigan Medical Center, Ann Arbor, Michigan; 4Division of Epidemiology, University of California Berkeley, School of Public Health, Berke-
ley, California; 5Department of Surgery, University of Michigan, Ann Arbor, Michigan; 6Department of Preventive Medicine, Keck School of Medicine, University of
Southern California, Los Angeles, California; 7Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey; 8Department of
Radiation Oncology, University of Michigan, Ann Arbor, Michigan; 9Department of Health Management and Policy, University of Michigan School of Public Health,
Ann Arbor, Michigan
Cancer May 1, 2011 1827
Original Article
Many studies have shown that worry varies by socio-
demographic factors5,14,17,18; however, most prior studies
have been limited by small, clinic-based samples, using
inconsistent measures. A major gap in knowledge is
whether worry differs across racial/ethnic groups,
including Latinos. Although Latinos are a racially and
socioculturally heterogeneous population,19 cultural
commonalities exist, including shared language, health
beliefs, and healthcare system experiences that impact
health and QOL outcomes.20 Two studies report that
Latinas have more worry than other groups,15,17 but these
studies do not consider the role of acculturation. When
acculturation has been measured across other health out-
comes, Latinas with low acculturation experience more
delay,10 lower decision satisfaction,9 and greater difficulty
with physician-patient communication.21
The association between clinical/treatment factors
and worry also needs to be further explored. Some studies
suggest more comorbidities and symptoms contribute to
greater worry,7,22 whereas others have found that receiv-
ing chemotherapy may be associated with worry.3,14,23
Finally, few studies have examined factors in the health-
care experience (eg, care coordination) that might eluci-
date differences in worry across vulnerable subgroups.
Negotiating the healthcare system remains an under-
studied element of acculturation.24 By better understand-
ing the influence of cultural adaptation on health and
disease, modifiable factors can be identified, high-risk
populations targeted, and interventions tailored to
specific components affecting risk.24
To address these gaps in the literature, we used a
large multiethnic population-based sample of women
with breast cancer to examine the following questions.
1) What are the sociodemographic, clinical, and treat-
ment correlates of reported worry about recurrence
as women transition into breast cancer survivorship?
2) Is patients’ appraisal of their healthcare experience
associated with worry about recurrence, and does
it mediate the relationship between worry and
sociodemographic, clinical, and treatment factors?
3) Are sociodemographic correlates of worry about




Between June 2005 and February 2007, 3252 women
aged 20 to 79 years diagnosed with primary ductal carci-
noma in situ or invasive breast cancer stages I, II, or III25
in Los Angeles (LA) and Detroit were selected for the
study. Of these women, 119 were excluded because: 1) the
physician did not want the patient contacted (n ¼ 20), 2)
the woman did not speak English or Spanish (n ¼ 17), 3)
the woman was too ill or incompetent to participate (n ¼
59), or 4) the woman denied having cancer (n ¼ 23). Of
3133 eligible women included in the final sample, 432
(13.8%) could not be located, and 411 (13.1%) were con-
tacted but did not return a survey. Thus, 2290 patients
returned a survey (73.1% response rate). The mean time
from diagnosis to survey completion was 9.2 months. Of
the women who completed the survey, 22 could not be
merged with the Surveillance, Epidemiology, and End
Results (SEER) program registries data, leaving an analytic
sample of 2268 (72.1% of eligible patients). Compared
with respondents, nonrespondents were more likely to be
African American (34.9% vs 26.2%, P < .001), be
unmarried (23.0% vs 19.3%, P ¼ .01), and have stage II
or III disease (43.4% vs 40.5%, P ¼ .005), and less likely
to receive lumpectomy (54.5% vs 63.2%, P¼ .02).
Population Sampling and Data Collection
Eligible breast cancer patients were accrued via rapid case
ascertainment as they were reported to the LA Cancer Sur-
veillance Program and the Metropolitan Detroit Cancer
Surveillance System. All African American women were
selected on demographic information from the treating
hospitals. Latina women in LA were selected by including
all women designated as Hispanic by the hospital, as well
as all women whose surname indicated a high probability
of being Latina, based on a list generated from the 1980
US Census. A random sample of the remaining white
patients in LA and Detroit were selected to reach the tar-
geted accrual number. Asian women in LA were excluded
because they were enrolled in other studies.
Physicians were notified of our intent to contact
their patients. If no objection was received, the patients
were mailed an introductory letter, survey materials, and a
$10 cash gift. Women from LA likely to be Latina based
on the US Spanish Surname list were sent both English
and Spanish materials. The Spanish survey was not used
in Detroit because few Hispanic women (50) were diag-
nosed with breast cancer and reported to the SEER regis-
try during the study.26 The Dillman survey method was
used to encourage survey response.27 The study protocol
was approved by the institutional review boards of the
University of Michigan, University of Southern Califor-
nia, andWayne State University.
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Survey Measures
The questionnaire was developed based on prior research
in the target population.9,10,23 Extensive piloting was
done with both English and Spanish versions. The Span-
ish survey was developed using rigorous translation
approaches including forward/back techniques to ensure
congruency between surveys. Internal consistency tests
were used to assess reliability of measures.
A modified stress/appraisal theoretical frame-
work28,29 adapted from Lazarus28 and used by Northouse
et al29 guided our survey (Fig. 1). According to the frame-
work, there are antecedent variables (eg, person, illness
related) and mediating variables (eg, appraisal factors)
that directly or indirectly affect QOL. We identified ante-
cedent variables (categorized into person and clinical/
treatment factors) and mediating factors (appraisal of
healthcare experience) potentially affecting worry.
Dependent Variable
Worry about recurrence was assessed with 3 items regard-
ing worry about cancer: 1) coming back in the same
breast, 2) occurring in the other breast, and 3) spreading
to other parts of the body. The 5-point Likert response
scale for each item ranged from ‘‘not at all’’ to ‘‘very
much,’’ with good internal consistency (Cronbach alpha
¼ .88). We created an overall worry about recurrence
score as the mean across items (higher scores indicate
more worry; range 1-5).
Independent Variables
Antecedent factors
Survey information on race and ethnicity was com-
bined to create the race/ethnicity variable. Women indi-
cated their race (white, black/African American,
American Indian or Alaska Native, Asian or Pacific
Islander, or other) and whether they were Hispanic/Latina
(yes/no). The Short Acculturation Scale for Hispanics,
developed by Marin and colleagues,30 is a widely used,
reliable, and valid measure to identify level of accultura-
tion.31,32 The 4 items in the Short Acculturation Scale for
Hispanics indicate preference for English or Spanish in
different contexts (usually read/speak, think, use at home,
use with friends) on a 5-point scale (‘‘English only’’ to
‘‘Spanish only’’). We aggregated across items to calculate a
mean score. Fifty-five percent of Latina patients scored
4 on the 5-point scale (strongly preferring Spanish
Figure 1. A modified stress appraisal conceptual model for understanding worry about recurrence is shown.
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across contexts). Race/ethnicity was thus divided into 4
categories (white, African American, Latinas-high accul-
turation [Latinas-high], and Latinas-low acculturation
[Latinas-low]). Compared with Latinas-high, Latinas-low
were much more likely to be foreign born (99.4% vs
35.2%). Additional demographic variables were age at
diagnosis (<50, 50-70, >70 years), education (<high
school [HS], HS diploma, >HS diploma), employment
status (yes/no), marital status (currently married/ part-
nered, divorced/widowed/separated, never married), and
income (<$20,000, $20,000-$69,999, $70,000þ,
unknown).
Clinical factors included family history of breast
cancer (first degree, no first degree) number of comorbid-
ities (0, 1, 2 or more), frequency of symptoms during
treatment (pain and fatigue on a 5-point Likert scale, ‘‘not
at all’’ to ‘‘very much’’), and stage at diagnosis (0, I, II/III).
Breast cancer stage was obtained via SEER data using the
American Joint Committee on Cancer criteria.25 Treat-
ment factors included surgical procedure (lumpectomy or
mastectomy), radiation therapy (yes/no), and chemother-
apy (yes/no).
Mediating factors
The patients’ appraisal of their healthcare experience
was measured across 3 factors: 1) ease of understanding
information, 2) symptom management, and 3) care coor-
dination. Ease of understanding information was measured
as the mean response to 2 items (5-point Likert scale,
from never to always): 1) ‘‘How often did you have prob-
lems understanding information about your breast cancer
and its treatment because of difficulty with written infor-
mation?’’ and 2) ‘How often did you have someone (like a
family member, hospital/clinic worker, or caregiver) help
you read written information from the hospital or clinic?’’
This scale ranged from 1 to 5, with a mean of 4.32, and
Cronbach alpha of .652. Symptom management was the
response to the question, ‘‘Do you think your doctor(s)
and their staff did everything they could to help you man-
age your symptoms’’ (5-point Likert scale from ‘‘not at
all’’ to ‘‘very much’’). This measure ranged from 1 to 5,
with a mean of 4.06. The care coordination items were
based on the Agency for Healthcare Research and Qual-
ity33 report and other cancer quality of care literature.34
The measure was the mean response to 5 items (5-point
Likert scale, never to always): 1) how often patients
received help from their surgeons with referrals to other
physicians,2 2) how often they knew whom to ask when
they had questions, 3) how often they were given confus-
ing advice (reverse coded), 4) how often they knew what
the next step in their treatment was, and 5) how often
their physicians had the medical information they needed.
The care coordination scale ranged from 1 to 5, with a
mean of 4.50 and Cronbach alpha of .697. Higher scores
for all 3 healthcare experience measures indicate more
understanding of information, better symptom manage-
ment, and better coordination of care. Multi-item scale
scores were calculated by averaging items. Each healthcare
experience measure was collapsed into 3 ordinal categories
(low, medium, high) to optimize the clarity of presenta-
tion. Other specifications of these variables (eg, interval
scale) yielded similar results.
Analysis Plan
Of the 2268 available for analysis, we omitted 431
(19.4%) women with missing values for any variable in
the analyses; thus, the final analytic sample included 1837
women. Sample weights were included to adjust for
design effects resulting from differential selection by race/
ethnicity and nonresponse. Descriptive statistics were
used to characterize the distribution of study covariates
overall and by mean worry score. Bivariate associations
were investigated between worry and sociodemographics,
clinical/treatment, and healthcare system factors. We also
tested bivariate associations between sociodemographics
and factors within the healthcare experience, an important
step is assessing mediation. Multivariate regression mod-
els investigated associations in a sequential modeling by
including sociodemographics and clinical/treatment fac-
tors in Model 1, and then adding the potential mediating
factors related to the healthcare experience in Model 2
(Research Question 2). All 2-way interactions between
sociodemographics and healthcare experience factors were
examined testing a moderating role (Research Question
3). All analyses were performed using SAS V9 program-
ming (SAS Institute, Cary, NC).
RESULTS
Table 1 displays the sample characteristics overall and by
mean worry scores. The mean age was 56.8 years (stand-
ard deviation ¼ 11.4), and 68.7%, 14.3%, 8.1%, and
8.9% were white, African American, Latinas-high, and
Latinas-low, respectively. In bivariate analyses, there were
significant differences in mean worry scores (all P values
<.001) for all sociodemographic variables except level of
income.
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White 870 68.7 2.74
Black 478 14.3 2.47
Latina (High acculturation) 233 8.1 3.08
Latina (Low acculturation) 256 8.9 3.78
Age <.001
<50 526 25.8 3.17
50-70 1064 59.6 2.81
>70 247 114.6 2.27
Education <.001
<High school diploma 331 12.7 3.23
High school diploma 374 19.3 2.86
>High school diploma 1132 68.0 2.73
Employed <.001
Yes 1061 58.6 2.92
No 776 41.4 2.68
Marital status .004
Married/partner 1049 60.6 2.89
Unmarried 788 39.4 2.72
Income, $ .274
<20,000 327 13.5 2.92
20,000- 69,999 677 36.4 2.84
‡70,000 505 32.4 2.75
Missing 328 17.7 2.83
Clinical Factors
Family history .282
First degree relative 342 19.4 2.76
No first degree relative 1495 80.6 2.84
Breast cancer stage .007
0 352 19.5 2.66
I 690 40.0 2.81
II/III 795 40.5 2.91
Number of co-morbidities .024
None 749 42.2 2.91
One 540 30.7 2.74
Two or more 548 27.1 2.77
Frequency of Pain <.001
None/A little 1029 56.5 2.55
Some 592 32.0 3.11
Quite a bit/very much 216 11.5 3.32
Frequency of Fatigue <.001
None/A little 498 25.6 2.43
Some 360 18.6 2.65
Quite a bit/very much 979 55.8 3.05
Treatment Factors
Surgical Procedure .048
Lumpectomy 1335 74.5 2.85
Mastectomy 502 25.5 2.72
Radiation therapy <.001
Yes 1307 70.7 2.93
No 530 29.3 2.57
Chemotherapy <.001
Yes 954 47.6 2.97
No 883 52.4 2.68
aWeighted percentage.
Worry About Recurrence in Breast Cancer/Janz et al
Cancer May 1, 2011 1831
Women who were younger, Latina, employed, mar-
ried, and less educated had higher levels of worry. More
worry was also reported by women with higher cancer
stage, fewer comorbidities, and more frequent pain and
fatigue during treatment (all Ps < .05). Women who had
lumpectomy compared with mastectomy reported more
worry, as did women who received radiation and/or
chemotherapy (all Ps< .05).
For the total sample, item mean levels of worry were
distributed as follows: 14% ‘‘not at all,’’ 32% ‘‘a little bit,’’
25% ‘‘somewhat,’’ 16% ‘‘quite a bit,’’ and 14% ‘‘very
much.’’ Figure 2 shows the percentage of women report-
ing levels of worry by race/ethnicity. Almost 29% of Afri-
can American women expressed low levels of worry
(corresponding to ‘‘not at all’’), compared with about
10%, 19%, and 20% for Latinas-low, Latinas-high, and
whites, respectively. Alternatively, almost 46% of Latinas-
low reported the highest category of worry (‘‘very much’’)
compared with 25%, 13%, and 14% for Latinas-high,
African American, and white women, respectively.
Figure 3 displays unadjusted mean worry scores for
the 3 healthcare experience factors. Greater ease in under-
standing information (3.14, 3.01, 2.68 for low, medium,
and high, P< .001), better symptom management (3.31,
2.85, 2.76 for low, medium, and high, P ¼ .001), and
more coordinated care (3.39, 2.91, 2.73, for low, me-
dium, and high, P< .001) were all significantly associated
with lower levels of worry.
In the multivariate findings (Table 2), where Model
1 adjusted for sociodemographic and clinical/treatment
factors, worry scores were significantly associated with
race/ethnicity, age, employment status, frequency of pain
and fatigue, and receipt of radiation therapy (all Ps <
.05). More worry was reported by Latinas (low and high)
than whites, and women who were younger, were
employed, had more comorbidities, had more pain and
fatigue, and who received radiation. In Model 2, which
further adjusted for the 3 factors from the healthcare expe-
rience, associations were only slightly reduced for sociode-
mographic, clinical, and treatment factors, with the
exception of the number of comorbidities, where the asso-
ciations were reduced and no longer significant (P ¼
.091). In this model, Latinas-low reported more worry
than other groups, with a worry score of 3.80 versus 3.17,
2.59, and 2.90 for Latinas-high, African Americans, and
whites (P< .001). Although worry continued to be signif-
icantly higher for Latinas-high than whites, the magnitude
of the differences were small, suggesting differences may
be a result of a large sample. African American women
reported significantly less worry than whites. Model 2 also
demonstrates associations between worry scores and
patients’ appraisal of their care experiences. Specifically,
less worry was associated with greater ease of understand-
ing information (P¼ .047), better management of symp-
toms (P ¼ .044), and more coordinated care (P ¼ .012).
We did not find any significant interactions between
sociodemographics and healthcare experience factors, sug-
gesting that sociodemographic factors and worry scores
were not modified by healthcare experience factors.
DISCUSSION
In this diverse population-based sample of newly diag-
nosed breast cancer patients, race, ethnicity, and accultur-
ation were associated with differences in worry about
recurrence after controlling for other sociodemographic,
clinical/treatment, and healthcare experience factors.
Latinas-low reported substantially more worry than white
women. Indeed, the mean difference was the largest
observed in the study (nearly 1 point in the 5-point
range). Several clinical studies with smaller samples
reported that Latinas are more likely to express worry and
Figure 3. Factors within the healthcare experience are
shown by worry about recurrence score (unadjusted).
Figure 2. Percentage of women reporting various levels of
worry about recurrence is shown by race/ethnicity.
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Table 2. Adjusted Mean Difference in Worry About Recurrence by Sociodemographic, Clinical, and Treatment Factors, and
Factors in the Health Care Experience
Model 1 P Model 2 P
Sociodemographic
Race/ethnicity <.001 <.001
Latina (low acculturation) .907a .862a
Latina (high acculturation) .272a .250a







<High school diploma - -
High schooldiploma .084 .080
>High schooldiploma -.060 -.048
Marital status .073 .079
Married/partner .106 .104
Not Married - -
Employed (yes) .132a .028 .120a .045






Family history .992 .941
First degree relative -.001 .005




Number of co-morbidities .044 .091
None - -
One .007 .010
Two or more .161a .143
Frequency of Pain <.001 <.001
None/a little - -
Some .333a .321a
Quite a bit/very Much .487a .477a
Frequency of Fatigue <.001 <.001
None/a little - -
Some .126 .122
Quite a bit/very Much .398a .388a
Treatment Factors
Surgical Procedure .120 .100
Lumpectomy - -
Mastectomy -.108 -.113
Radiation therapy (yes) .285a <.001 .290a <.001
Chemotherapy (yes) -.031 .657 -.113
Factors in the Health Care Experience












aP  .05 for the pair-wise comparison.
more emotional distress,15,17 but to our knowledge no
previous study has examined worry by level of accultura-
tion. In contrast, African American women reported
lower levels of worry, lending support to the growing liter-
ature indicating that African American women report
fewer concerns in the early survivorship period17 and have
higher emotional well-being than whites.35
Consistent with previous studies, we found
that younger women reported substantively more
worry.5,14,17,23,36,37 Younger women likely have fewer
peers with serious illness and find cancer more stressful,
having fewer coping resources.14 Whereas education did
not remain significant in the full model, being employed
was associated with more worry. Women who are
employed may worry more because of the consequences
of a recurrence on job stability.
Persistent pain and/or fatigue over the treatment pe-
riod were strongly associated with more worry at survey
completion. Possible explanations for this finding include
that the symptoms persisted and triggered greater worry,38
women had a heightened attentional focus on bodily
sensations resulting in greater worry (ie, somatoform ampli-
fication),39 and/or women who were anxious reported
more symptoms.40 In addition, the presence of comorbid-
ities may make it more difficult to interpret whether symp-
toms are because of cancer, resulting in higher worry.
Cancer stage was not independently associated with more
worry, consistent with many other studies.3,14,22,41 Current
health state may be a more powerful determinant of worry
than actual prognosis. Similar to prior studies, we found
that receipt of adjuvant therapy on subsequent worry was
inconsistent.3,14,22 Women who received radiation reported
more worry, whereas in the final model receipt of chemo-
therapy did not remain significant. Vickberg3 reasons that
because younger women report more fear and are more
likely to receive chemotherapy, chemotherapy is not signifi-
cant when age is in the model. The impact of aggressive
treatment on worry may vary depending on whether the
treatment course is viewed as signaling more serious disease
or as protection against recurrence. Radiation may have
remained significant because skin reactions may still have
been present for women receiving radiotherapy, serving as a
reminder of their diagnosis and treatment.
This study explored whether women’s appraisal of
their care experiences was associated with worry. Previous
studies suggest women are frequently dissatisfied with
information they receive regarding recurrence12 and gen-
erally desire more risk information.42 Our study and those
of others21 support that difficulty understanding informa-
tion and establishing a good relationship with their physi-
cian could contribute to greater worry. Although the
presence of symptoms during treatment was associated
with more worry later, women who perceived their symp-
toms were well managed reported less worry. Additional
attention to symptom management by providers could be
included in survivorship care plans and monitored at
follow-up. The challenge is to ensure women’s awareness
of signs of recurrence while not increasing anxious
preoccupation with excessive worry.43 The IOM report
on cancer survivors recommends patients receive a com-
prehensive care summary and follow-up plan to inform
and coordinate delivery of care,8,44 which may lead to
reduced worry, as supported by our findings.
Factors not measured in this study may explain why
racial/ethnic differences in worry persisted after healthcare
system experiences were assessed. Culture could impact
communication styles and/or perceptions of worry. For
African American women it may be culturally appropriate
to present a strong image, thereby reporting less worry,
whereas for Latinas it may be culturally appropriate to
express concerns and greater distress.17 Low acculturated
Latinas may perceive a higher likelihood of recurrence, per-
ceive the impact of a recurrence as more grave, or have
greater concerns about the consequences of a recurrence.3
Even controlling for insurance, education, and income,
racial/ethnic differences persisted, with Latinas-low report-
ing more worry. Finally, cultural variations in coping may
contribute to differences in worry. African American breast
cancer survivors report more social support18 and use more
religious-oriented coping17 than whites, whereas low accul-
turated Latinas report the lowest level of social support.37,42
Study findings are limited by the cross-sectional
design that did not allow for examination of worry over
time. Multiethnic longitudinal evaluations of worry are
needed to inform effective interventions to reduce dispar-
ities. It should be noted that our measure did not assess
the duration, frequency, and impact of distress on impair-
ment.3,45 Although the validity of attitudes measures are
difficult to fully evaluate, the worry measure was posi-
tively correlated with more symptoms during treatment,
and correlated with our QOL measure (FACT-B)46 sub-
scales as follows: physical well-being scale, r ¼ 0.313
(P < .001); emotional well-being scale, r ¼ 0.577
(P< .001) (unpublished).
Our study measures were self-reported and may be
subject to recall bias because of the time delay from treat-
ment to survey completion. However, we made consider-
able effort to address response bias through a rigorous
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translation process and pilot testing. Our previous publi-
cations have also supported the marked differences
between Latinas-low versus other groups across a broad
array of outcomes.9,10,35 Nevertheless, ethnicity and
acculturation cannot be fully untangled because our accul-
turation measure was language based and only assessed in
Latinas. A major study strength was the large population-
based sample with sufficient numbers of Latinas (predom-
inately fromMexico and Central America) to examine the
relevance of acculturation. Nevertheless, the US Hispanic
population is diverse, and it is not appropriate to general-
ize our findings to Latinas from other cultural
backgrounds.
Implications
Future research is needed to determine from whom, and
under what circumstances, cancer patients are receiving
risk information. We need to understand providers’ per-
ceptions about their responsibilities in informing and
addressing patients’ worries about recurrence. Validation
of women’s appraisal of the healthcare experience with the
actual receipt of services is an important area for future
research. Some of the mean differences we observed in
worry between groups, although significant, were small,
which may be a result of a large sample size. Further repli-
cation is needed to determine the clinical importance of
some of these findings.
For women with excessive worry, appropriate refer-
rals could be targeted at their unique concerns. These
interventions must be culturally sensitive, and tailored to
differences in communication style, social support, and
coping strategies. Continuing research must recognize the
multifaceted nature of women’s fears, including racial/
ethnic variation and acculturation differences in worry.
The influence of factors regarding a women’s experience
in the healthcare system deserves attention, as they hold
promise for system and policy interventions.
CONFLICT OF INTEREST DISCLOSURES
This work was funded by grants R01CA8837-A1 and
5R01CA109696-03 from the National Cancer Institute to the
University of Michigan. The collection of cancer incidence data
used in this study was supported by the California Department
of Health Services as part of the statewide cancer reporting pro-
gram mandated by California Health and Safety Code Section
103885; the National Cancer Institute (NCI)’s SEER program
under contract N01-PC-67010 awarded to the University of
Southern California, and contract N02-PC-15105 awarded to the
Public Health Institute; and the Centers for Disease Control and
Prevention’s National Program of Cancer Registries, under agree-
ment #U55/CCR921930 awarded to the Public Health Institute.
The collection of metropolitan Detroit cancer incidence data was
supported by the NCI SEER program contract N01-PC-65064.
The ideas and opinions expressed herein are those of the
author(s), and endorsement by the State of California, Depart-
ment of Public Health, National Cancer Institute, and Centers
for Disease Control and Prevention or their contractors and sub-
contractors is not intended nor should be inferred. Dr. Jagsi was
supported by the American Cancer Society.
REFERENCES
1. Lee-Jones C, Humphris G, Dixon R, Bebbington Hatcher
M. Fear of cancer recurrence—a literature review and pro-
posed cognitive formulation to explain exacerbation of re-
currence fears. Psychooncology. 1997;6:95-105.
2. van den Beuken-van Everdingen MH, Peters ML, de Rijke
JM, Schouten HC, van Kleef M, Patijn J. Concerns of for-
mer breast cancer patients about disease recurrence: a valida-
tion and prevalence study. Psychooncology. 2008;17:1137-
1145.
3. Vickberg SM. The concerns about recurrence scale (CARS):
a systematic measure of women’s fears about the possibility
of breast cancer recurrence. Ann Behav Med. 2003;25:16-24.
4. Baker F, Denniston M, Smith T, West MM. Adult cancer
survivors: how are they faring? Cancer. 2005;104:2565-
2576.
5. Kornblith AB, Powell M, Regan MM, et al. Long-term psy-
chosocial adjustment of older vs younger survivors of breast
and endometrial cancer. Psychooncology. 2007;16:895-903.
6. Gill KM, Mishel MH, Belyea M, et al. Triggers of uncer-
tainty about recurrence and long-term treatment side effects
in older African American and Caucasian breast cancer sur-
vivors. Oncol Nurs Forum. 2004;31:633-639.
7. Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana
B. Cancer-related health worries and psychological distress
among older adult, long-term cancer survivors. Psychooncol-
ogy. 2006;16:306-320.
8. Hewitt M, Greenfield S, Stovall E. From Cancer Patient to
Cancer Survivor: Lost in Transition. Washington, DC: The
National Academy Press; 2006.
9. Hawley ST, Griggs JJ, Hamilton AS, et al. Decision
involvement and receipt of mastectomy among racially and
ethnically diverse breast cancer patients. J Natl Cancer Inst.
2009;101:1337-1347.
10. Katz SJ, Lantz PM, Janz NK, et al. Patient involvement in
surgery treatment decisions for breast cancer. J Clin Oncol.
2005;23:5526-5533.
11. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies
on the rise? A 13-year trend analysis of the selection of mas-
tectomy versus breast conservation therapy in 5865 patients.
Ann Surg Oncol. 2009;16:2682-2690.
12. Gray RE, Fitch M, Greenberg M, Hampson A, Doherty M,
Labrecque M. The needs of well, longer-term survivors of
breast cancer. Patient Educ Couns. 1998;33:245-255.
13. Jiwa M, Thompson J, Coleman R, Reed M. Breast cancer
follow-up: could primary care be the right venue? Curr Med
Res Opin. 2006;22:625-630.
14. Costanzo ES, Lutgendorf SK, Mattes ML, et al. Adjusting to
life after treatment: distress and quality of life following treat-
ment for breast cancer. Br J Cancer. 2007;97:1625-1631.
15. Sammarco A, Konecny LM. Quality of life, social support,
and uncertainty among Latina breast cancer survivors. Oncol
Nurs Forum. 2008;35:844-849.
Cancer May 1, 2011 1835
Worry About Recurrence in Breast Cancer/Janz et al
16. Clayton MF, Mishel MH, Belyea M. Testing a model of
symptoms, communication, uncertainty, and well-being, in
older breast cancer survivors. Res Nurs Health. 2006;29:
18-39.
17. Spencer SM, Lehman JM, Wynings C, et al. Concerns
about breast cancer and relations to psychosocial well-being
in a multiethnic sample of early-stage patients. Health
Psychol. 1999;18:159-168.
18. Giedzinska AS, Meyerowitz BE, Ganz PA, Rowland JH.
Health-related quality of life in a multiethnic sample of
breast cancer survivors. Ann Behav Med. 2004;28:39-51.
19. Patcher LM, Weller SC, Baer RD, et al. Variation in
asthma beliefs and practices among mainland Puerto Ricans,
Mexican-Americans, Mexicans, and Guatemalans. J Asthma.
2002;39:119-134.
20. Vega WA, Rodriguez MA, Gruskin E. Health disparities in
the Latino population. Epidemiol Rev. 2009;31:99-112.
21. Ashing-Giwa KT, Padilla GV, Bohrquez DE, Tejero JS,
Garcia M. Understanding the breast cancer experience of
Latina women. J Psychosoc Oncol. 2006;24:19-52.
22. Mellon S, Kershaw TS, Northouse LL, Freeman-Gibb L. A
family-based model to predict fear of recurrence for cancer
survivors and their caregivers. Psychooncology. 2007;16:
214-223.
23. Janz NK, Mujahid MS, Lantz PM, et al. Population-based
study of the relationship of treatment and scoiodemo-
graphics on quality of life for early stage breast cancer. Qual
Life Res. 2005;14:1467-1479.
24. US Department of Health and Human Services. Epidemio-
logic Research in Hispanic Populations, Opportunities,
Barriers and Solutions.December 3, 2003. Available at:
http://www.nhlbi.nih.gov/meetings/workshops/hispanic.htm
Accessed September 7, 2010.
25. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM.
AJCC Cancer Staging Manual. 6th ed. Philadelphia, PA:
Lippincott Raven Publishers; 2002.
26. Centers for Disease Control and Prevention National Cancer
Institute. State Cancer Profiles: Dynamic Views for Cancer
Statistics for Prioritizing Cancer Control Efforts in the Nation,
States, and Counties. Available at: http://statecancerprofiles.
cancer.gov/incidencerates/index.php Accessed October 22,
2010.
27. Dillman DA. Mail and Telephone Surveys: The Total
Design Method. New York, NY: Wiley; 1997.
28. Lazarus RS. Evolution of a model of stress, coping, and dis-
crete emotions. In Rice VH, ed. Handbook of Stress, Cop-
ing, and Health. Thousand Oaks, CA: Sage; 2000:195-222.
29. Northouse LL, Mood D, Kershaw T, et al. Quality of life
of women with recurrent breast cancer and their family
members. J Clin Oncol. 2002;20:4050-4064.
30. Marin G, Sabogal F, VanOss Marin B, Otero-Sabogal F,
Perez-Stable EJ. Development of a short acculturation scale
for Hispanics. Hisp J Behav Sci. 1987;9:183-205.
31. Hamilton AS, Hofer TP, Hawley ST, et al. Latinas and
breast cancer outcomes: population-based sampling, ethnic
identity, and acculturation assessment. Cancer Epidemiol Bio-
markers Prev. 2009;18:2022-2029.
32. Hawley ST, Janz NK, Lillie SE, et al. Perceptions of care
coordination in a population-based sample of diverse breast
cancer patients. Patient Educ Couns. In press.
33. McDonald KM, Dundaram V, Bravata DM, et al, eds.
Closing the Quality Gap: A Critical Analysis of Quality
Improvement Strategies. Rockville, MD: Agency for Health-
care Research and Quality; 2007.
34. Bickell NA, Young GJ. Coordination of care for early-stage
breast cancer patients. J Gen Intern Med. 2001;16:737-
742.
35. Janz NK, Mujahid MS, Hawley ST, et al. Racial/ethnic dif-
ferences in quality of life after diagnosis of breast cancer.
J Cancer Surviv. 2009;4:212-222.
36. Friedman LC, Kalidas M, Elledge R, et al. Optimism, social
support and psychosocial functioning among women with
breast cancer. Psychooncology. 2006;15:595-603.
37. Ashing-Giwa K, Tejero JS, Kim J, Padilla GV, Hellemann
G. Examining predictive models of HRQOL in a popula-
tion-based, multiethnic sample of women with breast carci-
noma. Qual Life Res. 2007;16:413-428.
38. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic
pain in the cancer survivor: a new frontier. Pain Med.
2007;8:189-198.
39. Zachariae R, Paulsen K, Mehlsen M, Jensen AB, Johansson
A, von der Maase H. Chemotherapy-induced nausea, vomit-
ing, and fatigue–the role of individual differences related to
sensory perception and autonomic reactivity. Psychother
Psychosom. 2007;76:376-384.
40. Schnur JB, Ouellette SC, Dilorenzo TA, Green S, Montgomery,
GH. A qualitative analysis of acute skin toxicity among breast
cancer radiotherapy patients. Psychooncology. [published online
ahead of print March 17, 2010.]
41. Mathews A, Ridgeway V, Warren R, Britton P. Predicting
worry following a diagnosis of breast cancer. Psychooncology.
2002;11:415-418.
42. Janz NK, Mujahid MS, Hawley ST, Griggs JJ, Hamilton
AS, Katz SJ. Racial/ethnic differences in adequacy of infor-
mation and support for women with breast cancer. Cancer.
2008;113:1058-1067.
43. Armes J, Crowe M, Colbourne L, et al. Patients’ supportive
care needs beyond the end of cancer treatment: a prospec-
tive, longitudinal survey. J Clin Oncol. 2009;27:6172-6179.
44. Ganz PA. Survivorship: adult cancer survivors. Primary
Care. 2009;36:721-741.
45. Northouse LL. Mastectomy patients and the fear of cancer
recurrence. Cancer Nurs. 1981;4:213-220.
46. Cella D, Tulsky D, Gray G. The Functional Assessment of
Cancer Therapy Scale: development and validation of the
general measure. J Clin Oncol. 1993;11:570-579.
1836 Cancer May 1, 2011
Original Article
